Intensity Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
- Tuesday, September 5, 2023, 7:01
- Finance
- Add a comment
WESTPORT, Conn., Sept. 5, 2023 /PRNewswire/ — Intensity Therapeutics, Inc. (Nasdaq: INTS), a clinical-stage biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill tumors and increase immune system…
About the Author
adminasapcorp has written 39059 stories on this site.